Global Urinary Tract Infection Market
Urinary Tract Infection Market Size And Forecast
According To Verified Market Research, Global Urinary Tract Infection Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2019 to 2026.
Global Urinary Tract Infection Market Outlook
The major factor responsible for the growth of the global urinary tract infection market is the increasing prevalence of urinary tract infection across the globe. It is estimated, around 150 million people get affected with UTI every year. Moreover, increasing antibiotic resistance in bacteria causes to swell the UTI cases. The growing hospital-borne infections and growing geriatric population are also likely to fuel the market growth. However, increasing market fragmentation and unmet clinical requirements are some factors that might hinder the market growth.
Global Urinary Tract Infection Market Competitive Landscape
The Global Urinary Tract Infection Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as AstraZeneca, Bayer AG, Cipla Inc., GlaxoSmithKline, Hoffmann-La Roche Ltd, Johnson & Johnson, Novartis AG, Pfizer Inc., and Reddys Laboratories Ltd.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.